<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Nucl Med</journal-id><journal-id journal-id-type="iso-abbrev">Indian J Nucl Med</journal-id><journal-id journal-id-type="publisher-id">IJNM</journal-id><journal-title-group><journal-title>Indian Journal of Nuclear Medicine : IJNM : The Official Journal of the Society of Nuclear Medicine, India</journal-title></journal-title-group><issn pub-type="ppub">0972-3919</issn><issn pub-type="epub">0974-0244</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29430118</article-id><article-id pub-id-type="pmc">5798101</article-id><article-id pub-id-type="publisher-id">IJNM-33-57</article-id><article-id pub-id-type="doi">10.4103/ijnm.IJNM_107_17</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Penile Metastasis from Prostate Cancer Presenting as Malignant Priapism Detected Using Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kamaleshwaran</surname><given-names>Koramadai Karuppusamy</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Balasundararaj</surname><given-names>Barani Kumar Pollachi</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Jose</surname><given-names>Raghi</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Shinto</surname><given-names>Ajit Sugunan</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><italic>Department of Nuclear Medicine, PET/CT and Radionuclide Therapy, Coimbatore, Tamil Nadu, India</italic></aff><aff id="aff2"><label>1</label><italic>Department Urology, Kovai Medical Center and Hospital Limited, Coimbatore, Tamil Nadu, India</italic></aff><author-notes><corresp id="cor1"><italic><bold>Address for correspondence: </bold> Dr. Koramadai Karuppusamy Kamaleshwaran, Department of Nuclear Medicine, PET/CT and Radionuclide Therapy, Comprehensive Cancer Care Center, Kovai Medical Center and Hospital Limited, Coimbatore - 641 014, Tamil Nadu, India. E-mail: <email xlink:href="dr.kamaleshwar@gmail.com">dr.kamaleshwar@gmail.com</email></italic></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Mar</season><year>2018</year></pub-date><volume>33</volume><issue>1</issue><fpage>57</fpage><lpage>58</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2018 Indian Journal of Nuclear Medicine</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><p>Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography (Ga-68 PSMA PET/CT) is a promising diagnostic tool for patients with prostate cancer. Penile metastasis from prostate cancer is a rare phenomenon that infrequently manifests as malignant priapism. We present a case of 79-year-old patient diagnosed as a case of adenocarcinoma prostate presenting with penile metastases imaged using Ga-68 PSMA PET/CT.</p></abstract><kwd-group><kwd><italic>Gallium-68 prostate-specific membrane antigen positron emission tomography/computer tomography</italic></kwd><kwd><italic>penile metastasis</italic></kwd><kwd><italic>priapism</italic></kwd><kwd><italic>prostate cancer</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Gallium-68 prostate-specific membrane antigen positron emission tomography/computer tomography (Ga-68 PSMA PET/CT) is the best available imaging tool in the evaluation of prostate cancer.[<xref rid="ref1" ref-type="bibr">1</xref>] The penis is an uncommon site for metastasis originating from a prostate cancer. A review of the literature on penile metastases returned approximately 400 published cases, with priapism being the initial presentation in 20%&#x02013;50% of cases.[<xref rid="ref2" ref-type="bibr">2</xref>] Our case describes the image findings of Ga-68 PSMA PET/CT in an unusual case of prostate cancer with penile metastasis presenting with priapism.</p></sec><sec id="sec1-2"><title>Case Report</title><p>A 79-year-old male presented with a complaint of painful urinary outflow obstruction and persistent erection. Biopsy of prostate gland revealed carcinoma prostate (poorly differentiated adenocarcinoma, Gleason's score 3 + 4, initial prostate-specific antigen (PSA) &#x0003e;100 ng/ml). He was referred for the whole body Ga-68 PSMA PET/CT [<xref ref-type="fig" rid="F1">Figure 1</xref>] for staging which showed an enhancing lesion in the prostate gland (with a maximum standardized uptake value [SUVmax] of 16) and thickening of entire shaft of penis with intense PSMA uptake (SUVmax of 35) [<xref ref-type="fig" rid="F2">Figure 2</xref>]. He underwent bilateral orchidectomy and radiotherapy and is on follow-up.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Whole body Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography maximum projection image shows uptake in primary prostate lesion and penile metastasis</p></caption><graphic xlink:href="IJNM-33-57-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Sagittal computer tomography (a), positron emission tomography (b), positron emission tomography/computed tomography (c), maximum projection image (d), Gallium-68 prostate-specific membrane antigen positron emission tomography/computer tomography showing soft-tissue enhancing lesion in the prostate gland and corpora cavernosa thickening of penis with intense prostate-specific membrane antigen uptake suggesting metastasis</p></caption><graphic xlink:href="IJNM-33-57-g002"/></fig></sec><sec sec-type="discussion" id="sec1-3"><title>Discussion</title><p>Secondary penile lesions are a rare phenomenon, first described in 1870 by Eberth. Reviews of published case reports reveal that organs along the genitourinary tract, such as the prostate and bladder, are the most common primary sites. Of the 394 documented cases, 129 (33%) cases were of prostate origin, and bladder cancer was a close second with 118 published cases (30%).[<xref rid="ref2" ref-type="bibr">2</xref>] Clinical manifestations of penile metastases include penile masses or nodules, ulceration, obstructive or irritative urinary symptoms, hematuria, and malignant priapism in 20%&#x02013;50% of the documented cases.[<xref rid="ref3" ref-type="bibr">3</xref>]</p><p>Different mechanisms of persistent erection due to malignancy have been described, with a distinction between low-flow and high-flow priapism. Most incidences of malignant priapism are considered to be low-flow priapisms and are believed to be due to neoplastic invasions into the cavernous sinuses and venous system, causing a complete blockage, and a consequent unrelenting erection. The penile shaft is the most common anatomical site to be affected in case of a penile metastasis. Metastatic spread of prostate cancer to the penis occurs by several routes. Retrograde venous or direct lymphatic/vascular invasion and direct extension through the lumen of vas deferens are the most common mechanisms.[<xref rid="ref4" ref-type="bibr">4</xref>]</p><p>PSMA is a transmembrane protein that has considerable over expression on most prostate cancer cells. The whole body Ga-68 PSMA PET/CT have a high sensitivity in detecting lesions of prostate cancer with a high tumor to background contrast, even at low-serum PSA levels.[<xref rid="ref5" ref-type="bibr">5</xref>] Brain, liver, and penis are some of the organs which are uncommonly involved in carcinoma of the prostate. There are very few case reports till date which revealed detection of these sites on Ga-68 PSMA PET/CT. A case series' described three unusual sites of metastases (brain, penis, and liver) from prostate cancer.[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref>] Our case describes the first case of Ga-068 PSMA PET/CT detecting penile metastasis with priapism in the initial staging of prostate cancer.</p><p>Regardless of mechanism of spread or site of primary cancer, the prognosis of secondary penile malignancies is generally poor. It is reported that the average survival of such patients is approximately 9 months, with an overall survival of &#x0003c;18 months. Treatment of secondary penile lesions with malignant priapism has generally been aimed at palliation and improved quality of life, including surgical management of priapism and a possibility of penectomy for cutaneous lesions, urinary symptoms, and pain.[<xref rid="ref8" ref-type="bibr">8</xref>]</p><p>In conclusion, metastatic prostatic cancer presents with various signs and symptoms, and one should keep in mind the possibility of the penis as the site for metastasis. Ga-68 PSMA PET/CT scan allows detection of the metastatic sites, even the rare sites making it a powerful diagnostic tool for an assessment of the extent of disease in patients of prostate cancer.</p><sec id="sec2-1"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-2" sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afshar-Oromieh</surname><given-names>A</given-names></name><name><surname>Avtzi</surname><given-names>E</given-names></name><name><surname>Giesel</surname><given-names>FL</given-names></name><name><surname>Holland-Letz</surname><given-names>T</given-names></name><name><surname>Linhart</surname><given-names>HG</given-names></name><name><surname>Eder</surname><given-names>M</given-names></name><etal/></person-group><article-title>The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer</article-title><source>Eur J Nucl Med Mol Imaging</source><year>2015</year><volume>42</volume><fpage>197</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">25411132</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Luca</surname><given-names>F</given-names></name><name><surname>Zacharakis</surname><given-names>E</given-names></name><name><surname>Shabbir</surname><given-names>M</given-names></name><name><surname>Maurizi</surname><given-names>A</given-names></name><name><surname>Manzi</surname><given-names>E</given-names></name><name><surname>Zangh&#x000ec;</surname><given-names>A</given-names></name><etal/></person-group><article-title>Malignant priapism due to penile metastases: Case series and literature review</article-title><source>Arch Ital Urol Androl</source><year>2016</year><volume>88</volume><fpage>150</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">27377094</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philip</surname><given-names>J</given-names></name><name><surname>Mathew</surname><given-names>J</given-names></name></person-group><article-title>Penile metastasis of prostatic adenocarcinoma: Report of two cases and review of literature</article-title><source>World J Surg Oncol</source><year>2003</year><volume>1</volume><fpage>16</fpage><pub-id pub-id-type="pmid">14521716</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaux</surname><given-names>A</given-names></name><name><surname>Amin</surname><given-names>M</given-names></name><name><surname>Cubilla</surname><given-names>AL</given-names></name><name><surname>Young</surname><given-names>RH</given-names></name></person-group><article-title>Metastatic tumors to the penis: A report of 17 cases and review of the literature</article-title><source>Int J Surg Pathol</source><year>2011</year><volume>19</volume><fpage>597</fpage><lpage>606</lpage><pub-id pub-id-type="pmid">20075023</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurer</surname><given-names>T</given-names></name><name><surname>Eiber</surname><given-names>M</given-names></name><name><surname>Schwaiger</surname><given-names>M</given-names></name><name><surname>Gschwend</surname><given-names>JE</given-names></name></person-group><article-title>Current use of PSMA-PET in prostate cancer management</article-title><source>Nat Rev Urol</source><year>2016</year><volume>13</volume><fpage>226</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">26902337</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dureja</surname><given-names>S</given-names></name><name><surname>Thakral</surname><given-names>P</given-names></name><name><surname>Pant</surname><given-names>V</given-names></name><name><surname>Sen</surname><given-names>I</given-names></name></person-group><article-title>Rare sites of metastases in prostate cancer detected on ga-68 PSMA PET/CT scan-A case series</article-title><source>Indian J Nucl Med</source><year>2017</year><volume>32</volume><fpage>13</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">28242977</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasikumar</surname><given-names>A</given-names></name></person-group><article-title>Specificity of 68 Ga PSMA PET/CT for prostate cancer &#x02013; Myths and reality</article-title><source>Indian J Nucl Med</source><year>2017</year><volume>32</volume><fpage>11</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">28242976</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohan</surname><given-names>V</given-names></name><name><surname>Hanji</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>J</given-names></name><name><surname>Goswami</surname><given-names>J</given-names></name><name><surname>Tankshali</surname><given-names>R</given-names></name></person-group><article-title>Penile metastases from prostate cancer</article-title><source>Urol J</source><year>2009</year><volume>6</volume><fpage>217</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19711279</pub-id></element-citation></ref></ref-list></back></article>